> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Comments Reopened on Drug Naming Guidance
- URL: https://www.fdaweb.com/comments-reopened-on-drug-naming-guidance/
- Published: 2021-03-16T12:00:00.000Z
- Updated: 2026-09-14T16:50:58.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5148887

*Federal Register* notice: FDA is reopening the comment period on a 12/9/2020 notice entitled “Best Practices in Developing Proprietary Names for Human Nonprescription Drug Products; Draft Guidance for Industry; Availability.” Comments on the draft guidance should be submitted by 6/14 for the agency to consider them before it begins work on a final guidance. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2021-03-16/pdf/2021-05323.pdf?ref=fdaweb.com).